91Ó°ÊÓ

The R A S protein is a G-protein connected with the response to RTKs that initiates the M A P K kinase cascade when GDP is released and G T P uploaded. Mutations in the R A S protein which interfere with its GTPase activity are common in cancer. Evaluate the connection between the inability of R A S to hydrolyze G T P and uncontrolled cell proliferation. a. R A S, when bound to G T P, becomes permanently inactive even in the presence of the ligand, and no longer regulates cell division. b. R A S, when bound to G T P, becomes permanently active even in the absence of the ligand, and no longer regulates cell division. c. R A S, when bound to G T P, forms a dimer after binding to the ligand, and causes uncontrolled division, but it remains inactive when the ligand is absent. d. R A S, when bound to G T P, does not form a dimer after binding to the ligand but stimulates downstream signaling to occur and causes uncontrolled cell division.

Step by step solution

01

Understanding the role of RAS in cell signaling

The RAS protein is a G-protein that initiates the MAPK kinase cascade when GDP is released and GTP is bound. This cascade is crucial for regulating cell division.

02

Assessing the impact of GTPase mutations

Mutations in RAS that affect its GTPase activity result in the protein's inability to hydrolyze GTP to GDP. This means RAS remains in its active state.

03

Connecting inability to hydrolyze GTP with cell proliferation

When RAS cannot hydrolyze GTP, it remains bound to GTP and stays active continuously, leading to persistent downstream signaling regardless of ligand presence. This can cause uncontrolled cell proliferation, a characteristic of cancer.

04

Evaluating each choice

a. Incorrect. Permanent inactivity is not due to GTP binding but is associated with GDP binding.b. Correct. Continuous GTP binding keeps RAS active, leading to uncontrolled cell division without the ligand.c. Incorrect. The formation of dimers is not a usual function of RAS in signaling pathways.d. Incorrect. This does not fit the typical behavior of RAS in the context of mutations affecting GTPase activity.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

G-protein signaling

G-protein signaling plays a vital role in cellular communication. G-proteins are molecular switches that toggle between active and inactive states based on their binding to GTP or GDP. When a receptor tyrosine kinase (RTK) is activated by a ligand, it facilitates the exchange of GDP for GTP on the RAS G-protein. This switches RAS to an active state, initiating downstream signaling cascades.

The activated RAS protein can then interact with other proteins to propagate the signal through various pathways, like the MAPK kinase cascade, leading to various cellular responses, including growth and division. Understanding this signaling mechanism is crucial for grasping how mutations can lead to disorders like cancer.

MAPK kinase cascade

The MAPK kinase cascade is a critical signaling pathway that regulates numerous cellular activities, such as growth, division, and differentiation. This cascade is often initiated by the RAS protein once it is activated by GTP binding. The MAPK pathway includes a series of kinases that sequentially phosphorylate and activate each other. Usually, the pathway consists of three main levels: MAPKKK (MAP kinase kinase kinase), MAPKK (MAP kinase kinase), and MAPK (MAP kinase).

Each kinase phosphorylates the next in line, ultimately leading to the activation of specific transcription factors in the nucleus. These factors regulate the expression of genes involved in cell proliferation and survival. Dysregulation, particularly through mutations like those in RAS that keep it constitutively active, can lead to uncontrolled cell proliferation, contributing to cancer development.

GTPase activity

GTPase activity refers to the ability of G-proteins, like RAS, to hydrolyze GTP to GDP, effectively turning off the signal. Normally, RAS cycles between an active GTP-bound state and an inactive GDP-bound state. This cycling is crucial for tightly regulated signaling. Hydrolysis of GTP to GDP by the intrinsic GTPase activity of RAS effectively acts as a timer, ensuring that the signal is short-lived.

Mutations in RAS that impair its GTPase activity result in the protein being locked in the GTP-bound, active state. This leads to continuous signaling downstream of RAS, irrespective of external cues, such as ligand binding. This persistent, unregulated signaling can drive the cell into uncontrolled division and proliferation, a hallmark of cancer.

Uncontrolled cell proliferation

Uncontrolled cell proliferation is a primary feature of cancer. It occurs when cells divide and grow without the usual regulatory checks. Normal cell proliferation is tightly controlled by signaling pathways, such as the MAPK pathway, which are influenced by extracellular signals and internal regulatory mechanisms. Mutations in key components of these pathways can disrupt normal cell cycle control.

For instance, when mutations in the RAS protein prevent it from hydrolyzing GTP to GDP, RAS remains constantly active. This leads to continuous activation of downstream signaling pathways that promote cell division, even in the absence of growth signals. This scenario sets the stage for unchecked cell growth and tumor formation.

Cancer biology

Cancer biology studies the cellular and genetic changes that lead to cancer. At its core, cancer is a disease of dysregulated cell growth and division caused by genetic mutations. Many of these mutations occur in genes encoding proteins involved in controlling cell proliferation and survival.

Proteins like RAS play pivotal roles in transmitting growth signals from the cell surface to the nucleus. Mutations in RAS that lock it in its active form can lead to constant cell proliferation signals, bypassing the normal regulatory mechanisms. Understanding these molecular changes is imperative for developing targeted therapies in cancer treatment. Targeted therapies aim to specifically counteract the effects of these mutations, providing a more focused and effective treatment approach compared to traditional chemotherapy.